Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
39.44
-0.15 (-0.38%)
Oct 23, 2026, 4:00 PM EDT - Market closed
GRDN Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, GRDN stock has a consensus rating of "Strong Buy" and an average price target of $49.86. The average 1-year stock price forecast is 26.42% higher than the current stock price, while the lowest is $47 (+19.17%) and the highest is $52 (+31.85%).
Price Target: $49.86 (+26.42%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for GRDN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| KeyBanc No rating | KeyBanc | Buy Maintains $52 | Buy | Maintains | $52 | +31.85% | Oct 21, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $47 → $51 | Buy | Maintains | $47 → $51 | +29.31% | Sep 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $47 | Buy | Reiterates | $47 | +19.17% | Sep 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $43 → $49 | Buy | Maintains | $43 → $49 | +24.24% | Aug 7, 2026 |
Unknown Analyst Stephens No rating | Stephens | Buy Reiterates $50 | Buy | Reiterates | $50 | +26.77% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
1.44B
from 1.45B
Decreased by -0.47%
Revenue Next Year
1.53B
from 1.44B
Increased by 6.35%
EPS This Year
1.30
from 1.07
Increased by 21.63%
EPS Next Year
1.43
from 1.30
Increased by 10.21%
EPS and Forward PE are based on non-GAAP adjusted numbers.